These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39035183)

  • 1. The impact of centralized band purchasing of pharmaceuticals on innovation of Chinese pharmaceutical firms: an empirical study based on double difference models.
    Chen X; Chen S; Wu Z; Wang S; Chen Y
    Front Public Health; 2024; 12():1406254. PubMed ID: 39035183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does China's centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model.
    Gu Y; Zhuang Q
    Front Pharmacol; 2023; 14():1192423. PubMed ID: 37324496
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises' R&D investment: a difference-in-differences analysis in China.
    Li J; Zhang X; Wang R; Cao K; Wan L; Ren X; Ding J; Li W
    Front Public Health; 2024; 12():1402581. PubMed ID: 39011324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of China's National Centralized Drug Procurement Policy on pharmaceutical enterprises' financial performance: a quasi-natural experimental study.
    Sun Z; Na X; Chu S
    Front Public Health; 2023; 11():1227102. PubMed ID: 38026347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of centralized volume-based procurement of drugs on business performance of listed pharmaceutical enterprises.
    Ke Z; Zhang Y; Duan D
    Heliyon; 2024 Jun; 10(12):e33198. PubMed ID: 39021986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-examining the effect of carbon emission trading policy on improving the green innovation of China's enterprises.
    Yang S; Lu T; Huang T; Wang C
    Environ Sci Pollut Res Int; 2023 Jan; 30(3):7696-7717. PubMed ID: 36044137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital Transformation on Enterprise Green Innovation: Effect and Transmission Mechanism.
    Feng H; Wang F; Song G; Liu L
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Environmental Credit Rating Promote Green Innovation in Enterprises? Evidence from Heavy Polluting Listed Companies in China.
    Zuo M; Wu T
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact mechanism of environmental protection tax policy on enterprises' green technology innovation with quantity and quality from the micro-enterprise perspective.
    Du G; Zhou C; Ma Y
    Environ Sci Pollut Res Int; 2023 Jul; 30(33):80713-80731. PubMed ID: 37306881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Government subsidies and innovation in new energy vehicle companies: An empirical study of new energy vehicle listed companies based on Shanghai and Shenzhen A-shares.
    Sun J; Tian M; Zhang W; Ning J
    PLoS One; 2023; 18(4):e0284693. PubMed ID: 37079531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies-An Empirical Study Based on the Difference-in-Differences Model.
    Wei Y; Zhu J; Qiao J; Zhang D; Chen Y
    Front Public Health; 2022; 10():902025. PubMed ID: 35757628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of government subsidies on innovation of Chinese biopharmaceutical firms: Based on kink threshold model.
    Li Q; Di J; Liu Q
    Front Public Health; 2023; 11():1087830. PubMed ID: 36908409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impacts of China's dual carbon policy on green innovation: Evidence from Chinese heavy-polluting enterprises.
    Hong Y; Jiang X; Xu H; Yu C
    J Environ Manage; 2024 Jan; 350():119620. PubMed ID: 38000277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping with drug shortages: A study of government-enterprise option cooperation stockpiling strategies for drugs in shortage considering API surrogate stockpiling subsidies.
    Lan Y; Meng C; Sun L; Huang Z
    PLoS One; 2024; 19(7):e0305383. PubMed ID: 38954737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vacated space of volume/price of the drugs centralized procurement with quantity in secondary and above public hospitals of China.
    Wang J; Zhang S; Wang C; Li J; Wang R; Zhu L
    BMC Health Serv Res; 2024 Jun; 24(1):771. PubMed ID: 38951849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does green finance affect the innovation performance of enterprises? Evidence from China.
    Liu C; Dai C; Chen S; Zhong J
    Environ Sci Pollut Res Int; 2023 Jul; 30(35):84516-84536. PubMed ID: 37368205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on the mechanism of government subsidy on enterprise innovation based on industry-university-research collaboration.
    Zhao K; Yue D; Liu Y; Shan H
    Heliyon; 2024 May; 10(9):e30153. PubMed ID: 38694064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research on wind power industrial policies' functional mechanism to the quality of enterprise innovation.
    Wang X; Tao Z; Pan G; Zou H; Xie Y; Li X
    Environ Sci Pollut Res Int; 2023 Mar; 30(12):34350-34362. PubMed ID: 36509957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design.
    Hua YF; Lu J; Bai B; Zhao HQ
    Front Public Health; 2021; 9():809453. PubMed ID: 35178375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of perceived environmental uncertainty on green innovation: evidence from text recognition of Chinese listed companies' annual reports.
    Feng Y; Ma X
    Environ Sci Pollut Res Int; 2024 Jan; 31(5):7146-7166. PubMed ID: 38157182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.